发明名称 ARYLMETHOXY ISOINDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THE SAME AND METHODS OF USING THE SAME
摘要 PROBLEM TO BE SOLVED: To provide safe and effective methods of treating, preventing and managing cancer and other diseases and conditions, including diseases that are refractory to standard treatments, such as surgery, radiation therapy, chemotherapy and hormonal therapy, while reducing or avoiding toxicity and/or side effect associated with conventional therapies.SOLUTION: Provided are 4'-arylmethoxy isoindoline compounds represented by the formula in the figure, and pharmaceutically acceptable salts thereof, for treatment of cancer, a disorder associated with angiogenesis, pain, myodegeneration or a related syndrome, a skin disease, a pulmonary disorder, an asbestos-related disorder, a parasitic disease, an immunodeficiency disorder, a CNS disorder, CNS injury, atherosclerosis or a related disorder, dysfunctional sleep or a related disorder, an infectious disease, hemoglobinopathy or a related disorder, or a TNFα related disorder.SELECTED DRAWING: None
申请公布号 JP2016172746(A) 申请公布日期 2016.09.29
申请号 JP20160080097 申请日期 2016.04.13
申请人 CELGENE CORP 发明人 MAN HON-WAH;MULLER GEORGE W;ALEXANDER RUCHELMAN;EHAB M KHALIL;CHEN ROGER SHEN-CHU;ZHANG WEIHONG
分类号 C07D401/04;A61K31/4365;A61K31/4439;A61K31/444;A61K31/454;A61K31/4545;A61K31/4709;A61K31/4725;A61K31/496;A61K31/4985;A61K31/506;A61K31/517;A61K31/536;A61K31/5377;A61K31/538;A61K31/5386;A61K31/541;A61K31/553;A61P7/00;A61P9/10;A61P11/00;A61P17/00;A61P21/00;A61P25/00;A61P25/04;A61P25/20;A61P31/00;A61P31/18;A61P33/00;A61P35/00;A61P39/02;A61P43/00;C07D401/14;C07D405/14;C07D409/14;C07D413/14;C07D417/14;C07D471/04;C07D487/04;C07D491/08;C07D491/107;C07D495/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址